Press Releases OptimizeRx Corporation

Equities

OPRX

US68401U2042

Market Closed - Nasdaq Other stock markets 03:59:48 2024-05-29 pm EDT			5-day change	1st Jan Change
12.16 ^USD	-3.97%		-3.28%	-15.04%

May. 14	Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024
May. 14	OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OptimizeRx Reports First Quarter 2024 Financial Results	May. 14	AQ
OptimizeRx to Participate in Upcoming Investor Conferences	May. 06	AQ
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET	Apr. 26	AQ
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report	Apr. 18	AQ
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results	Apr. 16	AQ
OptimizeRx : ESG Report	Apr. 11	PU
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row	Apr. 11	AQ
OptimizeRx : Corporate Presentation	Apr. 05	PU
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET	Mar. 25	AQ
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023	Mar. 11	AQ
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort	Mar. 04	AQ
OptimizeRx to Participate in Upcoming Investor Conferences	Feb. 21	AQ
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape	Jan. 25	AQ
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update	Jan. 09	AQ
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco	Dec. 18	AQ
OptimizeRx Reports Third Quarter 2023 Financial Results	Nov. 06	AQ
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET	23-10-25	AQ
OptimizeRx : Third quarter 2023 headline numbers to come in ahead of consensus with revenue for OptimizeRx standalone expected to be between $15.2-$15.5 million and non-GAAP net income expected to be $0.6-$1 million - Form 8-K	23-10-16	PU
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers	23-10-12	AQ
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform	23-09-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases OptimizeRx Corporation

Equities

OPRX

US68401U2042

Press Releases

Filters